Nu Skin Enterprises, Inc. (NUS)
USD 7.04
(-3.83%)
USD 7.04
(-3.83%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 137.65 Million USD | -33.77% |
| 2022 | 231.84 Million USD | -38.46% |
| 2021 | 368.48 Million USD | 1.86% |
| 2020 | 331.55 Million USD | 23.98% |
| 2019 | 267.42 Million USD | -30.04% |
| 2018 | 394.54 Million USD | 39.26% |
| 2017 | 346.04 Million USD | 18.77% |
| 2016 | 303.5 Million USD | -5.56% |
| 2015 | 316.06 Million USD | -30.52% |
| 2014 | 407.11 Million USD | -36.44% |
| 2013 | 589.03 Million USD | 62.57% |
| 2012 | 374.25 Million USD | 41.6% |
| 2011 | 266.59 Million USD | 6.27% |
| 2010 | 246.67 Million USD | 28.88% |
| 2009 | 176.58 Million USD | 17.01% |
| 2008 | 138.84 Million USD | 2.97% |
| 2007 | 109.74 Million USD | 13.13% |
| 2006 | 86.9 Million USD | -18.74% |
| 2005 | 154.91 Million USD | 0.39% |
| 2004 | 125.75 Million USD | 11.97% |
| 2003 | 135.98 Million USD | 8.32% |
| 2002 | 105.81 Million USD | 36.4% |
| 2001 | 71.48 Million USD | -21.71% |
| 2000 | 128.01 Million USD | -25.73% |
| 1999 | 162.9 Million USD | -22.06% |
| 1998 | 210.8 Million USD | 38.87% |
| 1997 | 212.2 Million USD | 15.97% |
| 1996 | 149.2 Million USD | 117.08% |
| 1995 | 60.8 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 34.39 Million USD | 29.35% |
| 2024 Q2 | 41.39 Million USD | -412.05% |
| 2023 Q1 | 35.63 Million USD | -44.49% |
| 2023 FY | - USD | -33.77% |
| 2023 Q4 | 43.32 Million USD | 264.34% |
| 2023 Q3 | -26.36 Million USD | -144.18% |
| 2023 Q2 | 59.67 Million USD | 67.43% |
| 2022 FY | - USD | -38.46% |
| 2022 Q1 | 69.27 Million USD | -44.16% |
| 2022 Q2 | 70.16 Million USD | 1.28% |
| 2022 Q3 | 39.96 Million USD | -43.04% |
| 2022 Q4 | 64.19 Million USD | 60.64% |
| 2021 Q3 | 65.38 Million USD | -37.7% |
| 2021 FY | - USD | 1.86% |
| 2021 Q2 | 104.95 Million USD | 29.17% |
| 2021 Q1 | 81.25 Million USD | -24.35% |
| 2021 Q4 | 124.05 Million USD | 89.74% |
| 2020 Q2 | 58.07 Million USD | 58.82% |
| 2020 Q4 | 107.4 Million USD | 44.7% |
| 2020 FY | - USD | 23.98% |
| 2020 Q1 | 36.56 Million USD | -33.13% |
| 2020 Q3 | 74.22 Million USD | 27.82% |
| 2019 Q3 | 69.89 Million USD | -5.81% |
| 2019 Q2 | 74.2 Million USD | -15.93% |
| 2019 Q1 | 88.26 Million USD | -44.77% |
| 2019 FY | - USD | -30.04% |
| 2019 Q4 | 54.67 Million USD | -21.77% |
| 2018 Q3 | 103.36 Million USD | 24.89% |
| 2018 Q2 | 82.76 Million USD | 40.3% |
| 2018 FY | - USD | 39.26% |
| 2018 Q1 | 58.99 Million USD | -40.49% |
| 2018 Q4 | 159.8 Million USD | 54.6% |
| 2017 Q3 | 64.36 Million USD | -0.58% |
| 2017 Q2 | 64.73 Million USD | 1.33% |
| 2017 FY | - USD | 18.77% |
| 2017 Q1 | 63.88 Million USD | 5.11% |
| 2017 Q4 | 99.12 Million USD | 54.0% |
| 2016 Q1 | 8.14 Million USD | -86.8% |
| 2016 FY | - USD | -5.56% |
| 2016 Q2 | 79.79 Million USD | 879.24% |
| 2016 Q3 | 101.09 Million USD | 26.68% |
| 2016 Q4 | 60.78 Million USD | -39.87% |
| 2015 Q1 | 85.24 Million USD | -6.63% |
| 2015 FY | - USD | -30.52% |
| 2015 Q4 | 61.71 Million USD | 45.07% |
| 2015 Q3 | 42.54 Million USD | -52.37% |
| 2015 Q2 | 89.3 Million USD | 4.77% |
| 2014 Q4 | 91.29 Million USD | -13.01% |
| 2014 FY | - USD | -36.44% |
| 2014 Q1 | 101.19 Million USD | -46.34% |
| 2014 Q2 | 54.73 Million USD | -45.91% |
| 2014 Q3 | 104.95 Million USD | 91.75% |
| 2013 Q1 | 82.65 Million USD | -7.02% |
| 2013 FY | - USD | 62.57% |
| 2013 Q4 | 188.59 Million USD | 12.08% |
| 2013 Q3 | 168.27 Million USD | 46.86% |
| 2013 Q2 | 114.58 Million USD | 38.62% |
| 2012 FY | - USD | 41.6% |
| 2012 Q4 | 88.9 Million USD | 9.58% |
| 2012 Q1 | 68.02 Million USD | -11.63% |
| 2012 Q2 | 101.28 Million USD | 48.88% |
| 2012 Q3 | 81.12 Million USD | -19.9% |
| 2011 Q1 | 33.24 Million USD | -43.25% |
| 2011 FY | - USD | 6.27% |
| 2011 Q2 | 66.17 Million USD | 99.03% |
| 2011 Q4 | 76.97 Million USD | 3.89% |
| 2011 Q3 | 74.09 Million USD | 11.97% |
| 2010 Q3 | 53.56 Million USD | -19.38% |
| 2010 Q4 | 58.58 Million USD | 9.36% |
| 2010 FY | - USD | 28.88% |
| 2010 Q1 | 45.5 Million USD | 4.87% |
| 2010 Q2 | 66.44 Million USD | 46.03% |
| 2009 Q3 | 45.4 Million USD | 23.74% |
| 2009 Q4 | 43.39 Million USD | -4.43% |
| 2009 Q1 | 47.56 Million USD | 30.72% |
| 2009 Q2 | 36.69 Million USD | -22.87% |
| 2009 FY | - USD | 17.01% |
| 2008 FY | - USD | 2.97% |
| 2008 Q1 | 41.22 Million USD | -35.78% |
| 2008 Q4 | 36.38 Million USD | -20.94% |
| 2008 Q3 | 46.02 Million USD | 43.0% |
| 2008 Q2 | 32.18 Million USD | -21.91% |
| 2007 Q4 | 64.18 Million USD | 135.55% |
| 2007 FY | - USD | 13.13% |
| 2007 Q2 | 28.26 Million USD | 8.04% |
| 2007 Q1 | 26.16 Million USD | -21.01% |
| 2007 Q3 | 27.25 Million USD | -3.59% |
| 2006 Q2 | 31.65 Million USD | -13.23% |
| 2006 Q4 | 33.11 Million USD | 19.69% |
| 2006 Q1 | 36.48 Million USD | 1.6% |
| 2006 FY | - USD | -18.74% |
| 2006 Q3 | 27.67 Million USD | -12.59% |
| 2005 Q3 | 39.69 Million USD | -13.91% |
| 2005 FY | - USD | 0.39% |
| 2005 Q1 | 36.94 Million USD | -8.89% |
| 2005 Q2 | 46.1 Million USD | 24.79% |
| 2005 Q4 | 35.91 Million USD | -9.53% |
| 2004 Q3 | 41 Million USD | -9.86% |
| 2004 Q4 | 40.55 Million USD | -1.1% |
| 2004 Q1 | 30.99 Million USD | -29.72% |
| 2004 FY | - USD | 11.97% |
| 2004 Q2 | 45.49 Million USD | 46.78% |
| 2003 Q1 | 19.71 Million USD | -28.72% |
| 2003 Q4 | 43.41 Million USD | 5.34% |
| 2003 Q2 | 25.73 Million USD | 23.22% |
| 2003 Q3 | 35.83 Million USD | 37.39% |
| 2003 FY | - USD | 8.32% |
| 2002 Q4 | 34.25 Million USD | 7.96% |
| 2002 FY | - USD | 36.4% |
| 2002 Q1 | 20.47 Million USD | 8.14% |
| 2002 Q2 | 30.42 Million USD | 47.33% |
| 2002 Q3 | 25.94 Million USD | -15.03% |
| 2001 Q1 | 21.48 Million USD | -39.65% |
| 2001 Q3 | 19.65 Million USD | -7.07% |
| 2001 Q2 | 27.87 Million USD | 104.28% |
| 2001 Q4 | 26.71 Million USD | -13.95% |
| 2001 FY | - USD | -21.71% |
| 2000 Q4 | 29.74 Million USD | -28.02% |
| 2000 Q2 | 34.56 Million USD | 21.89% |
| 2000 Q1 | 30.75 Million USD | 1.64% |
| 2000 FY | - USD | -25.73% |
| 2000 Q3 | 32.94 Million USD | -5.59% |
| 1999 FY | - USD | -22.06% |
| 1999 Q4 | 28.5 Million USD | -36.16% |
| 1999 Q3 | 39.6 Million USD | 18.21% |
| 1999 Q2 | 39.9 Million USD | -28.63% |
| 1999 Q1 | 55 Million USD | -10.61% |
| 1998 Q1 | 55.1 Million USD | 62.27% |
| 1998 Q3 | 50 Million USD | 14.11% |
| 1998 Q4 | 59.4 Million USD | 26.65% |
| 1998 FY | - USD | 38.87% |
| 1998 Q2 | 46.4 Million USD | -22.31% |
| 1997 Q2 | 57.8 Million USD | 30.09% |
| 1997 Q3 | 53.3 Million USD | -14.54% |
| 1997 Q4 | 39.5 Million USD | -15.98% |
| 1997 FY | - USD | 15.97% |
| 1997 Q1 | 47 Million USD | 110.17% |
| 1996 Q2 | 163.5 Million USD | 31.64% |
| 1996 Q1 | 124.2 Million USD | 168.02% |
| 1996 Q3 | 183.6 Million USD | 12.29% |
| 1996 Q4 | -343 Million USD | -286.82% |
| 1996 FY | - USD | 117.08% |
| 1995 Q3 | 83.2 Million USD | 3.35% |
| 1995 Q4 | -182.6 Million USD | -319.47% |
| 1995 Q1 | 77.7 Million USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q2 | 80.5 Million USD | 3.6% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Church & Dwight Co., Inc. | 1.25 Billion USD | 89.06% |
| Colgate-Palmolive Company | 4.5 Billion USD | 96.947% |
| The Clorox Company | 736 Million USD | 81.296% |
| Coty Inc. | 1 Billion USD | 86.29% |
| The Estée Lauder Companies Inc. | 2.4 Billion USD | 94.274% |
| e.l.f. Beauty, Inc. | 188.31 Million USD | 26.899% |
| Edgewell Personal Care Company | 285.4 Million USD | 51.767% |
| Grove Collaborative Holdings, Inc. | -21.29 Million USD | 746.494% |
| Hims & Hers Health, Inc. | -19.93 Million USD | 790.43% |
| Kimberly-Clark Corporation | 3.06 Billion USD | 95.512% |
| Kenvue Inc. | 3.17 Billion USD | 95.664% |
| The Procter & Gamble Company | 23.84 Billion USD | 99.423% |
| Spectrum Brands Holdings, Inc. | 323.9 Million USD | 57.5% |